← back to search

Freya Garhöfer

University Hospital Heidelberg · DE
Area of research
Genetics · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Glioblastoma and Radiomics, with related work in Progression-free survival, Atlas (anatomy), Epilepsy. Notable publications include 'Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma', 'Mapping glioblastoma-induced neurological deficits: A brain atlas', and 'Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patients'.
h-index
citations
7
works
3
NIH funding
primary concept
email

Recent publications

Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma
Journal of Neuro-Oncology 2025cited by 3position: middledoi
Mapping glioblastoma-induced neurological deficits: A brain atlas
Clinical Neurology and Neurosurgery 2025cited by 2position: middledoi
Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patients
Frontiers in Oncology 2025cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Felix T. Kurz · University of Geneva3 papers (2025–2025)Martin Bendszus · University Hospital and Clinics3 papers (2025–2025)K Holz · University Hospital Heidelberg3 papers (2025–2025)Felix Sahm · Heidelberg (Poland)3 papers (2025–2025)Sabine Heiland · Heidelberg University3 papers (2025–2025)Anja Hohmann · University Hospital Heidelberg3 papers (2025–2025)Varun Venkataramani · DKFZ-ZMBH Alliance3 papers (2025–2025)Johann M. E. Jende · German Cancer Research Center3 papers (2025–2025)Heinz-Peter Schlemmer · German Cancer Research Center3 papers (2025–2025)Sabine Wolf · University Hospital Heidelberg3 papers (2025–2025)Yeong Chul Yun · German Cancer Research Center3 papers (2025–2025)Wolfgang Wick · German Cancer Research Center2 papers (2025–2025)Philipp Kickingereder · University of Bonn2 papers (2025–2025)Karl‐Olof Lövblad · University of Lausanne1 papers (2025–2025)Wolfgang Wick · German Cancer Research Center1 papers (2025–2025)